- Trials with a EudraCT protocol (104)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (7)
104 result(s) found for: Central Venous Catheter.
Displaying page 1 of 6.
EudraCT Number: 2012-002469-37 | Sponsor Protocol Number: CRO-2012-17 | Start Date*: 2012-09-28 | |||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO | |||||||||||||
Full Title: Phase II clinical study on the efficacy and safety of procedural analgesia of oral transmucosal fentanyl citrate in oncologic patients eligible to permanent central venous catheter | |||||||||||||
Medical condition: Cancer patients eligible to permanent central venous catheter due to chemotherapeutic treatment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000874-36 | Sponsor Protocol Number: 2014PAED13L | Start Date*: 2015-10-30 | |||||||||||
Sponsor Name:Norfolk and Norwich University Hospitals NHS Trust | |||||||||||||
Full Title: The efficacy and safety of two topical antiseptic solutions for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: a feasibility study | |||||||||||||
Medical condition: Central venous catheter-related sepsis in premature neonates | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001340-22 | Sponsor Protocol Number: CathLockTrialHD | Start Date*: 2020-02-24 |
Sponsor Name:Universtitätsklinikum St.Pölten | ||
Full Title: A prospective, randomized, multicenter trial to compare a Taurolock™ based lock solution to a Citrate and Citrate/Urokinase based lock solution in tunneled hemodialysis catheters for the prevention... | ||
Medical condition: Patients requiring hemodialysis with a CVC due to renal failure of any cause. Aim of this study is to investigate different CVC lock Solutions. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000801-25 | Sponsor Protocol Number: RC06/21 | Start Date*: 2021-12-10 | |||||||||||
Sponsor Name:IRCCS MATERNO INFANTILE BURLO GAROFOLO | |||||||||||||
Full Title: Intranasal dexmedetomidine: pilot pharmacokinetics / pharmacodynamics (PK/PD) study in a preterm population undergoing percutaneous central venous catheter placement | |||||||||||||
Medical condition: Preterm newborns of less than/or equal to 36 weeks of gestational age who have an umbilical venous or arterial catheter which, for nutritional and/or therapeutic needs, must be replaced by a percut... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003194-24 | Sponsor Protocol Number: CPI-226-03 | Start Date*: 2006-01-02 |
Sponsor Name:Cadence Pharmaceuticals, Inc. | ||
Full Title: Estudio en fase III, multicéntrico, aleatorizado, con enmascaramiento del tratamiento para el comité de evaluación para valorar la eficacia de la administración tópica de omiganán al 1,0% en gel en... | ||
Medical condition: Prevención de infecciones en la zona del catéter. Prevention of local site infections in patients requiring central venous and/or arterial catheterization and/or peripherally inserted central veno... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004826-28 | Sponsor Protocol Number: ict-bem-2004-02 | Start Date*: 2005-03-28 | |||||||||||
Sponsor Name:Instituto Científico y Tecnológico de Navarra | |||||||||||||
Full Title: Multicenter double-blind placebo controlled aleatorized study to evaluate the efficacy and safety of bemiparin (3500 IU/day) in thromboprophylaxis in cancer paients with central vein catheter | |||||||||||||
Medical condition: Deep Vein Thrombosis related central vein catheter (DVT-CVC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024597-19 | Sponsor Protocol Number: CV185-079 | Start Date*: 2011-06-21 | ||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | ||||||||||||||||||
Full Title: Multiple-Dose Study Apixaban in Pediatric Subjects with an Indwelling Central Venous Catheter Revised Protocol 03, to incorporate Protocol amendments 1, 3 & 4 | ||||||||||||||||||
Medical condition: Prevention of VTE in pediatric subject with a central venous cathether. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) NL (Ongoing) Outside EU/EEA | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019984-12 | Sponsor Protocol Number: AMNCH-TCD-CHG-1-2010 | Start Date*: 2010-07-21 |
Sponsor Name:Adelaide & Meath Hospital, incorporating The National Children's Hospital | ||
Full Title: A multicentre randomised trial comparing the effects of 2% chlorhexidine gluconate in 70% isopropyl alcohol as a skin, exit site and catheter hub cleansing agent versus other forms of chlorhexidine... | ||
Medical condition: Prevention of central venous catheter-related infections in haemodialysis patients. This trial will evaluate the effectiveness of 2% chlorhexidine gluconate in 70%isopropyl alcohol as a skin, exit... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001511-54 | Sponsor Protocol Number: A5951060 | Start Date*: 2004-12-08 | |||||||||||
Sponsor Name:Pfizer Global Research and Development | |||||||||||||
Full Title: Linezolid vs. Vancomycin/Oxacillin/Dicloxacillin in the Treatment of Catheter-Related Gram Positive Bloodstream Infections. | |||||||||||||
Medical condition: Catheter related gram positive bloodstream infection | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002896-32 | Sponsor Protocol Number: D5136C00001 | Start Date*: 2013-01-16 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A multicenter, double-blind, placebo-controlled, pharmacokinetic, pharmacodynamic, safety and tolerability study in patients aged 12 to <18 years of age with a central venous catheter to support pr... | |||||||||||||
Medical condition: Thrombosis, thromboembolism | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001845-15 | Sponsor Protocol Number: TINCRBEL_study | Start Date*: 2018-07-13 |
Sponsor Name:Academic medical centre, department of internal medicine | ||
Full Title: EvaluaTion of Clinical and laboratory outcomes of Rivaroxaban in short Bowel syndrome patients dEpending on Long term parenteral nutrition: a prospective cohort study (TINCRBEL study) | ||
Medical condition: Chronic intestinal failuyre (IF) is caused by large surgical bowel resection, severe motility, or absorption diseorders. These patientds require partial or total parenteral nutrition (PN and TPN, r... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015163-14 | Sponsor Protocol Number: 73191198 | Start Date*: 2010-01-08 | ||||||||||||||||
Sponsor Name:Department of Pediatrics Aarhus University Hospital Skejby | ||||||||||||||||||
Full Title: Reduction of hypertrophic scars and keloid by use of corticosteroid cream after removal of a tunneled central venous catheter in childhood cancer survivors | ||||||||||||||||||
Medical condition: Development of hypertrophic and keloid scars after removal of tunneled central venous catheters in childhood cancer survivors | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002124-32 | Sponsor Protocol Number: CUSA-081-HEM-01 | Start Date*: 2020-01-02 |
Sponsor Name:Chiesi Farmaceutici S.p.A. | ||
Full Title: READY 1: A Phase 3, Randomized, Double-Blind, Active and Placebo-Controlled Study on the use of CUSA-081 for Dysfunctional Central Venous Access Devices (CVADs) | ||
Medical condition: Catheter Occlusion Thrombosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) BE (Completed) ES (Prematurely Ended) RO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002158-59 | Sponsor Protocol Number: SÖSPN | Start Date*: 2018-09-05 |
Sponsor Name:Södersjukhuset | ||
Full Title: A prospective study of the safety of peripherally administered norepinephrine during surgery | ||
Medical condition: Hypotension during general anaesthesia or central blockades | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000595-32 | Sponsor Protocol Number: Ematonco/divmalinf/2006.1 | Start Date*: 2006-09-06 | |||||||||||
Sponsor Name:ISTITUTO GIANNINA GASLINI | |||||||||||||
Full Title: Rescue therapy for indwelling central venous Hickmann-Broviac catheter related infections with antibiotic lock technique | |||||||||||||
Medical condition: Patients with Hemato-oncologic disease or undergoing Hematopoietic stem cell transplantation | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000675-15 | Sponsor Protocol Number: 06RP02 | Start Date*: 2006-09-11 |
Sponsor Name:Great Ormond Street Hospital for Children NHS Trust | ||
Full Title: Open label Randomised Controlled Trial comparing povidone-iodine 10% with alcohol and 0.5% chlorhexidine with alcohol for prevention of early infection associated with insertion of central venous a... | ||
Medical condition: Potential Systematic Sepsis | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-010190-20 | Sponsor Protocol Number: 0908010 | Start Date*: 2009-04-22 | |||||||||||
Sponsor Name:CHU Saint-Etienne | |||||||||||||
Full Title: DETECTION OF ACUTE RENAL FAILURE IN CRITICALLY ILL PATIENTS: A prospective evaluation of cystatin C diagnostic performance | |||||||||||||
Medical condition: critically ill patients hospitalised in inetnsive care unit | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000545-19 | Sponsor Protocol Number: HA008 | Start Date*: 2006-08-03 | |||||||||||
Sponsor Name:Nuvelo, Inc. | |||||||||||||
Full Title: Phase 3, Multicenter, Multi-National, Open-Label Study to Evaluate the Safety and Efficacy of Alfimeprase in Subjects with Occluded Central Venous Access Devices | |||||||||||||
Medical condition: Central venous access device withdrawl occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003843-28 | Sponsor Protocol Number: STH13565 | Start Date*: 2005-03-18 |
Sponsor Name:Sheffield Teaching Hospitals NHS Foundation Trust | ||
Full Title: The acute effects of testosterone administration in patients with pulmonary hypertension | ||
Medical condition: Pulmonary Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002094-55 | Sponsor Protocol Number: 1861 | Start Date*: 2019-09-09 |
Sponsor Name:Universitair Ziekenhuis Brussel, Belgium | ||
Full Title: Safety and feasibility of S-Caine patch use in children under the age of three | ||
Medical condition: children under the age of three that are in possession of a central catheter and under permanent monitoring (healthy, or any condition) | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.